A transcriptional initiator overlaps with a conserved YY1 binding site in the long control region of human papillomavirus type 16

Virology

Volumn 305, Issue 2, 2003, Pages 486-501

  Tan, Shyh Han ^a,d   Baker, Carl C ^b   Stünkel, Walter ^a   Bernard, Hans Ulrich ^a,c  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; TRANSCRIPTION FACTOR; VIRUS GLYCOPROTEIN;

ARTICLE; BINDING SITE; CELL CULTURE; CELL NUCLEUS MATRIX; DOWNSTREAM PROCESSING; EPISOME; GENE ACTIVITY; GENE FUNCTION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; REPORTER GENE; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0037455541     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1779     Document Type: Article

References (63)

1. Ai W., Toussaint E., Roman A. CCAAT displacement protein binds to and negatively regulates human papillomavirus type 6 E6, E7, and E1 promoters. J. Virol. 73:1999;4220-4229.
2. Baker C. C., Howley P. M. Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues. EMBO J. 6:1987;1027-1035.
3. Baker C. C., Phelps W. C., Lindgren V., Braun M. J., Gonda M. A., Howley P. M. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61:1987;962-971.
4. Basu A., Park K., Atchison M. L., Carter R. S., Avadhani N. G. Identification of a transcriptional initiator element in the cytochrome c oxidase subunit Vb promoter which binds to transcription factors NF-E1 (YY-1, delta) and Sp1. J. Biol. Chem. 268:1993;4188-4196.
5. Bauknecht T., Angel P., Royer H. D., zur Hausen H. Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: Interaction with the transcriptional repressor YY1. EMBO J. 11:1992;4607-4617.
6. Bogomolski-Yahalom V., Klein A., Greenblat I., Haviv Y., Tur-Kaspa R. The TATA-less promoter of hepatitis B virus S gene contains a TBP binding site and an active initiator. Virus Res. 49:1997;1-7.
7. Carcamo J., Buckbinder L., Reinberg D. The initiator directs the assembly of a transcription factor IID-dependent transcription complex. Proc. Natl. Acad. Sci. USA. 88:1991;8052-8056.
8. Chalkley G. E., Verrijzer C. P. DNA binding site selection by RNA polymerase II TAFs: A TAF(II)250-TAF(II)150 complex recognizes the initiator. EMBO J. 18:1999;4835-4845.
9. Chenchik A., Zhu Y. Y., Diatchenko L., Li R., Hill J., Siebert P. D. Siebert P., Larrick J. Gene Cloning and Analysis by RT-PCR. 1998;305-319 Biotechniques Books, Natick.
10. Cripe T. P., Haugen T. H., Turk J. P., Tabatabai F., Schmid P. G. 3rd, Durst M., Gissmann L., Roman A., Turek L. P. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: Implications for cervical carcinogenesis. EMBO J. 6:1987;3745-3753.
11. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
12. Dollard S. C., Broker T. R., Chow L. T. Regulation of the human papillomavirus type 11 E6 promoter by viral and host transcription factors in primary human keratinocytes. J. Virol. 67:1993;1721-1726.
13. Du H., Roy A. L., Roeder R. G. Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters. EMBO J. 12:1993;501-511.
14. Gloss B., Bernard H. U., Seedorf K., Klock G. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J. 6:1987;3735-3743.
15. Grassmann K., Rapp B., Maschek H., Petry K. U., Iftner T. Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA. J. Virol. 70:1996;2339-2349.
16. Guo B., Odgren P. R., van Wijnen A. J., Last T. J., Nickerson J., Penman S., Lian J. B., Stein J. L., Stein G. S. The nuclear matrix protein NMP-1 is the transcription factor YY1. Proc. Natl. Acad. Sci. USA. 92:1995;10526-10530.
17. Hahn S. The Yin and Yang of mammalian transcription. Curr. Biol. 2:1992;152-154.
18. Haller K., Stubenrauch F., Pfister H. Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions. Virology. 214:1995;245-255.
19. Houbaviy H. B., Usheva A., Shenk T., Burley S. K. Cocrystal structure of YY1 bound to the adeno-associated virus P5 initiator. Proc. Natl. Acad. Sci. USA. 93:1996;13577-13582.
20. Hyde-DeRuyscher R. P., Jennings E., Shenk T. DNA binding sites for the transcriptional activator/repressor YY1. Nucleic Acids Res. 23:1995;4457-4465.
21. IARC, 1995, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. v. 64: Human Papillomaviruses, (, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Eds.), International Agency for Research on Cancer, World Health Organization, Lyon, France.
22. Javahery R., Khachi A., Lo K., Zenzie-Gregory B., Smale S. T. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol. Cell Biol. 14:1994;116-127.
23. Jeon S., Allen-Hoffmann B. L., Lambert P. F. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69:1995;2989-2997.
24. Kanaya T., Kyo S., Laimins L. A. The 5′ region of the human papillomavirus type 31 upstream regulatory region acts as an enhancer which augments viral early expression through the action of YY1. Virology. 237:1997;159-169.
25. Kaufmann J., Smale S. T. Direct recognition of initiator elements by a component of the transcription factor IID complex. Genes Dev. 8:1994;821-829.
26. Kaufmann J., Verrijzer C. P., Shao J., Smale S. T. CIF, an essential cofactor for TFIID-dependent initiator function. Genes Dev. 10:1996;873-886.
27. Kraus R. J., Murray E. E., Wiley S. R., Zink N. M., Loritz K., Gelembiuk G. W., Mertz J. E. Experimentally determined weight matrix definitions of the initiator and TBP binding site elements of promoters. Nucleic Acids Res. 24:1996;1531-1539.
28. Maldonado E., Shiekhattar R., Sheldon M., Cho H., Drapkin R., Rickert P., Lees E., Anderson C. W., Linn S., Reinberg D. A human RNA polymerase II complex associated with SRB and DNA-repair proteins. Nature. 381:1996;86-89.
29. Martinez E., Chiang C. M., Ge H., Roeder R. G. TATA-binding protein-associated factor(s) in TFIID function through the initiator to direct basal transcription from a TATA-less class II promoter. EMBO J. 13:1994;3115-3126.
30. May M., Dong X. P., Beyer-Finkler E., Stubenrauch F., Fuchs P. G., Pfister H. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J. 13:1994;1460-1466.
31. Myers, G, Bernard, H. U, Delius, H, Baker, C, Icenogle, J, Halpern, A, and, Wheeler, C, Eds, 1995, Human Papillomaviruses. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences, Los Alamos National Laboratory, Los Alamos, New Mexico.
32. O'Connor M., Chan S. Y., Bernard H. U. Transcription factor binding sites in the long control regions of genital HPVs. Myers G., Bernard H. U., Delius H., Baker C., Icenogle J., Halpern A., Wheeler C. Human Papillomaviruses 1995 Compendium. 1995;21-40 Los Alamos National Laboratory, Los Alamos.
33. O'Connor M. J., Stunkel W., Zimmermann H., Koh C. H., Bernard H. U. A novel YY1-independent silencer represses the activity of the human papillomavirus type 16 enhancer. J. Virol. 72:1998;10083-10092.
34. O'Connor M. J., Tan S. H., Tan C. H., Bernard H. U. YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J. Virol. 70:1996;6529-6539.
35. Ozbun M. A., Meyers C. Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol. 71:1997;5161-5172.
36. Ozbun M. A., Meyers C. Two novel promoters in the upstream regulatory region of human papillomavirus type 31b are negatively regulated by epithelial differentiation. J. Virol. 73:1999;3505-3510.
37. Park K., Atchison M. L. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3′ enhancer and the immunoglobulin heavy-chain mu E1 site. Proc. Natl. Acad. Sci. USA. 88:1991;9804-9808.
38. Purnell B. A., Gilmour D. S. Contribution of sequences downstream of the TATA element to a protein-DNA complex containing the TATA-binding protein. Mol. Cell Biol. 13:1993;2593-2603.
39. Roy A. L., Du H., Gregor P. D., Novina C. D., Martinez E., Roeder R. G. Cloning of an inr- and E-box-binding protein, TFII-I, that interacts physically and functionally with USF1. EMBO J. 16:1997;7091-7104.
40. Roy A. L., Meisterernst M., Pognonec P., Roeder R. G. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature. 354:1991;245-248.
41. Seto E., Shi Y., Shenk T. YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro. Nature. 354:1991;241-245.
42. Shi Y., Seto E., Chang L. S., Shenk T. Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell. 67:1991;377-388.
43. Skalnik D. G., Strauss E. C., Orkin S. H. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J. Biol. Chem. 266:1991;16736-16744.
44. Smale S. T. Transcription initiation from TATA-less promoters within eukaryotic protein-coding genes. Biochim. Biophys. Acta. 1351:1997;73-88.
45. Smale S. T., Baltimore D. The "initiator" as a transcription control element. Cell. 57:1989;103-113.
46. Steger G., Corbach S. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J. Virol. 71:1997;50-58.
47. Stenlund A., Botchan M. R. The E2 trans-activator can act as a repressor by interfering with a cellular transcription factor. Genes Dev. 4:1990;123-136.
48. Stenlund A., Bream G. L., Botchan M. R. A promoter with an internal regulatory domain is part of the origin of replication in BPV-1. Science. 236:1987;1666-1671.
49. Stubenrauch F., Leigh I. M., Pfister H. E2 represses the late gene promoter of human papillomavirus type 8 at high concentrations by interfering with cellular factors. J. Virol. 70:1996;119-126.
50. Stünkel W., Bernard H. U. The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression. J. Virol. 73:1999;1918-1930.
51. Stünkel W., Huang Z., Tan S. H., O'Connor M., Bernard H. U. Nuclear matrix attachment regions of human papillomavirus-16 repress or activate the E6 promoter depending on the physical state of the viral DNA. J. Virol. 74:2002;2489-2501.
52. Swindle C. S., Zou N., Van Tine B. A., Shaw G. M., Engler J. A., Chow L. T. Human papillomavirus DNA replication compartments in a transient DNA replication system. J. Virol. 73:1999;1001-1009.
53. Tan S. H., Bartsch D., Schwarz E., Bernard H. U. Nuclear matrix attachment regions of human papillomavirus type 16 point toward conservation of these genomic elements in all genital papillomaviruses. J. Virol. 72:1998;3610-3622.
54. Tan S. H., Leong L. E., Walker P. A., Bernard H. U. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J. Virol. 68:1994;6411-6420.
55. Usheva A., Shenk T. YY1 transcriptional initiator: Protein interactions and association with a DNA site containing unpaired strands. Proc. Natl. Acad. Sci. USA. 93:1996;13571-13576.
56. Vande Pol S. B., Howley P. M. A bovine papillomavirus constitutive enhancer is negatively regulated by the E2 repressor through competitive binding for a cellular factor. J. Virol. 64:1990;5420-5429.
57. Veenstra G. J., Wolffe A. P. Gene-selective developmental roles of general transcription factors. Trends Biochem. Sci. 26:2001;665-671.
58. Verrijzer C. P., Chen J. L., Yokomori K., Tjian R. Binding of TAFs to core elements directs promoter selectivity by RNA polymerase II. Cell. 81:1995;1115-1125.
59. Weis L., Reinberg D. Accurate positioning of RNA polymerase II on a natural TATA-less promoter is independent of TATA-binding-protein-associated factors and initiator-binding proteins. Mol. Cell Biol. 17:1997;2973-2984.
60. Wettstein F. O., Barbosa M. S., Nasseri M. Identification of the major cottontail rabbit papillomavirus late RNA cap site and mapping and quantitation of an E2 and minor E6 coding mRNA in papillomas and carcinomas. Virology. 159:1987;321-328.
61. Wieczorek E., Brand M., Jacq X., Tora L. Function of TAF(II)-containing complex without TBP in transcription by RNA polymerase II. Nature. 393:1998;187-191.
62. Wu Y., Patterson C. The human KDR/flk-1 gene contains a functional initiator element that is bound and transactivated by TFII-I. J. Biol. Chem. 274:1999;3207-3214.
63. Zenzie-Gregory B., O'Shea-Greenfield A., Smale S. T. Similar mechanisms for transcription initiation mediated through a TATA box or an initiator element. J. Biol. Chem. 267:1992;2823-2830.